scholarly article | Q13442814 |
P50 | author | Wayne K. Goodman | Q20740908 |
David Mataix-Cols | Q42603887 | ||
Lee Baer | Q114238439 | ||
Michael A Jenike | Q114527804 | ||
P2093 | author name string | Scott L Rauch | |
Steven A Rasmussen | |||
Jane L Eisen | |||
David M Shera | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obsessive-compulsive disorder | Q178190 |
P304 | page(s) | 263-268 | |
P577 | publication date | 2002-02-01 | |
P1433 | published in | American Journal of Psychiatry | Q1935368 |
P1476 | title | Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study | |
P478 | volume | 159 |
Q34021432 | A 5-year course of predominantly obsessive vs. mixed subtypes of obsessive-compulsive disorder |
Q51892933 | A challenging task for assessment of checking behaviors in obsessive-compulsive disorder. |
Q91650564 | A comparison of symptom dimensions for obsessive compulsive disorder and obsessive compulsive-related disorders |
Q47093839 | A multilevel longitudinal study of obsessive compulsive symptoms in adolescence: male gender and emotional stability as protective factors |
Q48221197 | Adding motivational interviewing and thought mapping to cognitive-behavioral group therapy: results from a randomized clinical trial |
Q36881849 | An epidemiological perspective of obsessive-compulsive disorder in children and adolescents. |
Q35561526 | Anxiety disorders in women |
Q46071340 | Are obsessive-compulsive symptom dimensions familial in nonclinical individuals? |
Q33763009 | Assessing Older Adults' Obsessive-Compulsive Disorder Symptoms: Psychometric Characteristics of the Obsessive Compulsive Inventory-Revised. |
Q36599213 | Clinical predictors of drug response in patients with obsessive-compulsive disorder |
Q35012507 | Cognitive Bias Modification (CBM) of obsessive compulsive beliefs |
Q37286806 | Cognitive performance in a subclinical obsessive-compulsive sample 1: cognitive functions |
Q64989717 | Comparing OCD-affected youth with and without religious symptoms: Clinical profiles and treatment response. |
Q50712303 | Compulsive hoarding: an interpretative phenomenological analysis. |
Q36642394 | DISTINCT ETIOLOGICAL INFLUENCES ON OBSESSIVE-COMPULSIVE SYMPTOM DIMENSIONS: A MULTIVARIATE TWIN STUDY. |
Q52096858 | Deep brain stimulation of the anterior limb of the internal capsule for treatment of therapy-refractory obsessive compulsive disorder (OCD): a case study highlighting neurocognitive and psychiatric changes. |
Q37682681 | Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder |
Q37775991 | Disgust in contamination-based obsessive-compulsive disorder: a review and model |
Q40537511 | EFFECTS OF HOMEWORK COMPLIANCE ON COGNITIVE-BEHAVIORAL THERAPY WITH D-CYCLOSERINE AUGMENTATION FOR CHILDREN WITH OBSESSIVE COMPULSIVE DISORDER. |
Q46119652 | Evidence for a heritable unidimensional symptom factor underlying obsessionality |
Q40603956 | Examination of a Bifactor Model of Obsessive-Compulsive Symptom Dimensions |
Q25257180 | Exploratory analysis of obsessive compulsive symptom dimensions in children and adolescents: a prospective follow-up study |
Q51915542 | Family accommodation in pediatric obsessive-compulsive disorder. |
Q37893917 | Functional neuroimaging in obsessive-compulsive disorder. |
Q35550845 | Genetic and environmental influences on obsessive-compulsive behaviour across development: a longitudinal twin study |
Q34335067 | In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD). |
Q37136969 | Internet-Based Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder in Korea |
Q36214868 | Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial |
Q50578030 | Is late-onset OCD a distinct phenotype? Findings from a comparative analysis of "age at onset" groups. |
Q51909687 | Longitudinal assessment of symptom and subtype categories in obsessive-compulsive disorder. |
Q47570444 | Manipulating an internal pulse generator until twiddler's syndrome in a patient treated with deep brain stimulation for obsessive-compulsive disorder |
Q36244176 | Measuring anxiety: are we getting what we need? |
Q37678101 | Meta-analysis of the symptom structure of obsessive-compulsive disorder |
Q34678136 | Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial. |
Q46865596 | N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder |
Q48361357 | Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers |
Q50932533 | Non-erotic thoughts: content and relation to sexual functioning and sexual satisfaction. |
Q47221294 | OCD symptoms in a sample of Turkish patients: a phenomenological picture |
Q42056614 | Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions |
Q58635766 | Obsessive-Compulsive Symptoms among Spanish Adolescents: Prevalence and Association with Depressive and Anxious Symptoms |
Q54088077 | Obsessive-compulsive disorder |
Q92353027 | Obsessive-compulsive disorder |
Q35237204 | Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts |
Q37444564 | Obsessive-compulsive disorder for ICD-11: proposed changes to the diagnostic guidelines and specifiers |
Q36470804 | Obsessive-compulsive disorder in pregnancy and the postpartum period: course of illness and obstetrical outcome. |
Q34378597 | Obsessive-compulsive disorder phenotypes: implications for genetic studies |
Q33375375 | Obsessive-compulsive disorder spectrum as a scientific "metaphor". |
Q74759516 | Obsessive-compulsive disorder with and without tics in a clinical sample of children and adolescents |
Q28275558 | Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V |
Q38212792 | Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective |
Q35095197 | Obsessive-compulsive spectrum of disorders: a defensible construct? |
Q56627228 | Obsessive–Compulsive Spectrum of Disorders: A Defensible Construct? |
Q82377575 | Obsessive–compulsive disorder in children and adolescents. Symptom dimensions in a naturalistic setting |
Q34377437 | Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period |
Q33875407 | Paroxetine treatment of compulsive hoarding |
Q35719153 | Patterns of neural response to emotive stimuli distinguish the different symptom dimensions of obsessive-compulsive disorder. |
Q36471100 | Psychometric properties of the DY-BOCS in a Turkish sample of children and adolescents |
Q38465299 | Psychopharmacological treatment differences in autogenous and reactive obsessions: A retrospective chart review. |
Q36548195 | Sexual obsessions and suicidal behaviors in patients with mood disorders, panic disorder and schizophrenia. |
Q37700925 | Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? |
Q48850199 | Study of neurocognitive endophenotypes in drug-naïve obsessive-compulsive disorder patients, their first-degree relatives and healthy controls |
Q61654711 | Subtyping OCD: Prospects and problems |
Q60634324 | Subtyping obsessive-compulsive disorder: A taxometric analysis |
Q36364449 | Symptom Dimensions in Obsessive-Compulsive Disorder and Obsessive Beliefs |
Q91602743 | Symptom dimensions in obsessive-compulsive disorder as predictors of neurobiology and treatment response |
Q36827123 | Symptom dimensions in obsessive-compulsive disorder: implications for the DSM-V. |
Q37214734 | Symptom subtypes of obsessive-compulsive disorder: are they relevant for treatment? |
Q57847999 | Temporal Stability of Obsessive-Compulsive Symptom Dimensions in an Undergraduate Sample |
Q34487447 | The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions |
Q46884720 | The Netherlands Obsessive Compulsive Disorder Association (NOCDA) study: design and rationale of a longitudinal naturalistic study of the course of OCD and clinical characteristics of the sample at baseline. |
Q48863871 | The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems |
Q84461967 | Typology of obsessive-compulsive symptoms in children and adolescents with anorexia nervosa |
Q28732413 | When too much is not enough: obsessive-compulsive disorder as a pathology of stopping, rather than starting |
Search more.